272 related articles for article (PubMed ID: 23861236)
1. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
[TBL] [Abstract][Full Text] [Related]
2. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
[TBL] [Abstract][Full Text] [Related]
3. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
[TBL] [Abstract][Full Text] [Related]
4. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
[TBL] [Abstract][Full Text] [Related]
5. Genetic risk markers related to diabetes-associated autoantibodies in young patients with type 1 diabetes in berlin, Germany.
Kordonouri O; Hartmann R; Charpentier N; Knip M; Danne T; Ilonen J
Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):245-9. PubMed ID: 20140847
[TBL] [Abstract][Full Text] [Related]
6. Triple specificity of ZnT8 autoantibodies in relation to HLA and other islet autoantibodies in childhood and adolescent type 1 diabetes.
Andersson C; Vaziri-Sani F; Delli A; Lindblad B; Carlsson A; Forsander G; Ludvigsson J; Marcus C; Samuelsson U; Ivarsson S; Lernmark A; Larsson HE;
Pediatr Diabetes; 2013 Mar; 14(2):97-105. PubMed ID: 22957668
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR-DQ haplotypes and specificity of the initial autoantibody in islet specific autoimmunity.
Mikk ML; Pfeiffer S; Kiviniemi M; Laine AP; Lempainen J; Härkönen T; Toppari J; Veijola R; Knip M; Ilonen J;
Pediatr Diabetes; 2020 Nov; 21(7):1218-1226. PubMed ID: 32613719
[TBL] [Abstract][Full Text] [Related]
8. Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes.
Knip M; Kukko M; Kulmala P; Veijola R; Simell O; Akerblom HK; Ilonen J
Am J Med Genet; 2002 May; 115(1):48-54. PubMed ID: 12116176
[TBL] [Abstract][Full Text] [Related]
9. Associations of polymorphisms in non-HLA loci with autoantibodies at the diagnosis of type 1 diabetes: INS and IKZF4 associate with insulin autoantibodies.
Lempainen J; Härkönen T; Laine A; Knip M; Ilonen J;
Pediatr Diabetes; 2013 Nov; 14(7):490-6. PubMed ID: 23721563
[TBL] [Abstract][Full Text] [Related]
10. Positivity for Zinc Transporter 8 Autoantibodies at Diagnosis Is Subsequently Associated With Reduced β-Cell Function and Higher Exogenous Insulin Requirement in Children and Adolescents With Type 1 Diabetes.
Juusola M; Parkkola A; Härkönen T; Siljander H; Ilonen J; Åkerblom HK; Knip M;
Diabetes Care; 2016 Jan; 39(1):118-21. PubMed ID: 26519333
[TBL] [Abstract][Full Text] [Related]
11. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
[TBL] [Abstract][Full Text] [Related]
12. Progression to type 1 diabetes and autoantibody positivity in relation to HLA-risk genotypes in children participating in the ABIS study.
Gullstrand C; Wahlberg J; Ilonen J; Vaarala O; Ludvigsson J
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):182-90. PubMed ID: 18331414
[TBL] [Abstract][Full Text] [Related]
13. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
[TBL] [Abstract][Full Text] [Related]
15. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
17. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z
Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067
[TBL] [Abstract][Full Text] [Related]
18. Zinc transporter 8 autoantibodies in patients with type 1 diabetes from a multiethnic population and their first degree relatives.
Araujo DB; Skärstrand H; Barone B; Dantas JR; Kupfer R; Zajdenverg L; Milech A; Vaziri-Sani F; Oliveira JE; Rodacki M
Arq Bras Endocrinol Metabol; 2014 Oct; 58(7):737-43. PubMed ID: 25372583
[TBL] [Abstract][Full Text] [Related]
19. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
[TBL] [Abstract][Full Text] [Related]
20. Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study.
Vehik K; Bonifacio E; Lernmark Å; Yu L; Williams A; Schatz D; Rewers M; She JX; Toppari J; Hagopian W; Akolkar B; Ziegler AG; Krischer JP;
Diabetes Care; 2020 Sep; 43(9):2066-2073. PubMed ID: 32641373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
